Literature DB >> 13016039

Oxytetracycline-streptomycin therapy in brucellosis due to Brucella melitensis.

G B MAGILL, J H KILLOUGH.   

Abstract

Entities:  

Keywords:  BRUCELLOSIS/therapy; STREPTOMYCIN/therapeutic use; TERRAMYCIN/therapeutic use

Mesh：

Substances：

Year:  1953        PMID： 13016039     DOI： 10.1001/archinte.1953.00240140064005

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  10 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Possible implications of doxycycline-rifampin interaction for treatment of brucellosis.

Authors:  J D Colmenero; L C Fernández-Gallardo; J A Agúndez; J Sedeño; J Benítez; E Valverde
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

3.  Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks.

Authors:  J M Cisneros; P Viciana; J Colmenero; J Pachón; C Martinez; A Alarcón
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

4.  Treatment of human brucellosis with doxycycline and gentamicin.

Authors:  J Solera; A Espinosa; E Martínez-Alfaro; L Sánchez; P Geijo; E Navarro; J Escribano; J A Fernández
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

Review 5.  Recognition and optimum treatment of brucellosis.

Authors:  J Solera; E Martínez-Alfaro; A Espinosa
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

6.  Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin.

Authors:  M Akova; O Uzun; H E Akalin; M Hayran; S Unal; D Gür
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

7.  Trimethoprim-sulphamethoxazole in acute brucellosis.

Authors:  A Hassan; M M Erian; Z Farid; S D Hathout; K Sorensen
Journal:  Br Med J       Date:  1971-07-17

8.  Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.

Authors:  J Solera; M Rodríguez-Zapata; P Geijo; J Largo; J Paulino; L Sáez; E Martínez-Alfaro; L Sánchez; M A Sepulveda; M D Ruiz-Ribó
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

9.  Brucellosis with nephrotic syndrome, nephritis and IgA nephropathy.

Authors:  N Siegelmann; A S Abraham; B Rudensky; O Shemesh
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401

10.  Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis.

Authors:  J Ariza; F Gudiol; R Pallarés; G Rufí; P Fernández-Viladrich
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.